Betamethasone Sodium Phosphate — Drug Intelligence | 46 EU Trials

Filter these 46 trials by condition, phase, country and more.

Open in Search →

46 Registered trials

17 Recruiting

23 Completed trials

30 Sponsors

23 Countries

Phase III

Phase II

Phase III: 21 Phase II/III: 3 Phase II: 13 Phase I/II: 4 Phase IV: 4 Phase I (FiH): 1

Oversight events:

1 serious breach 1 temporary halt 2 urgent safety measures 2 unexpected events across 4 trials

View oversight register →

Indications tested

Diffuse large B-cell lymphoma 4 Small cell lung cancer extensive stage 2 Follicular lymphoma stage III 1 Non-small cell lung cancer metastatic 1 Rheumatoid arthritis 1 Adenovirus infection 1 Follicular lymphoma stage II 1 Mantle cell lymphoma 1 Retinitis pigmentosa 1 Crigler-Najjar syndrome 1 H1N1 influenza 1 Primary myelofibrosis 1

Sponsors using this IMP

Merck Sharp & Dohme LLC 6 Assistance Publique Hopitaux De Paris 4 Genmab A/S 4 Celgene Corp. 3 Amgen Inc. 2 AstraZeneca AB 2 Kite Pharma Inc. 2 Universitaetsklinikum Heidelberg AöR 2 Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino 1 Azienda Provinciale Per I Servizi Sanitari 1 Fakultni Nemocnice Plzen 1 Fondazione Italiana Linfomi Ets 1

All trials

46 total

Stroke in childhood due to inflammatory narrowing of blood vessels: Treatment with steroids Pending

2022-500631-36-00 Phase III 5 countries Insel Gruppe AG
Progression under Olaparib: a randomized phaSE II trIal with docetaxel or carboplatin-docetaxel DOublet in mCRPC patieNts Pending

2023-503676-25-01 Phase II 1 country Azienda Provinciale Per I Servizi Sanitari
A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active convent… Pending

2024-516723-14-00 Phase IV 4 countries Karolinska Institutet
Double-blind randomized controlled study versus placebo to evaluate the efficacy of mono-administration of betamethasone in children with sy… Pending

2024-518095-31-00 Phase III 1 country Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino
EFFECT OF DEXAMETASONE ON LOWER LIMB EDEMA IN PATIENTS UNDERTAKEN FOR TOTAL HIP ARTHROPLASTY Pending

2024-518133-28-00 Phase IV 1 country Hospital Universitari De Girona Doctor Josep Trueta
A randomized controlled, two-arm (1:1 ratio) Phase IIa trial to assess the efficacy and safety of obinutuzumab in treating adults with de no… Pending

2025-520641-69-00 Phase II 3 countries Medizinische Universitaet Innsbruck
A clinical trial of MK-1045 and rituximab in people with follicular lymphoma (MK-1045-007) Recruiting

2025-522777-10-00 Phase II/III 2 countries Merck Sharp & Dohme LLC
A randomized phase 3, double-blind, placebo-controlled study of elacestrant plus everolimus versus elacestrant in patients with estrogen rec… Recruiting

2024-512926-27-00 Phase III 7 countries Medica Scientia Innovation Research S.L.; Stemline Therapeutics Inc.
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited‑Stage Small‑Cell Lung Cancer (DeLLphi-306) Recruiting

2023-506235-15-00 Phase III 12 countries Amgen Inc.
A multi-center phase III randomized study comparing continuous versus fixed duration therapy with Daratumumab, Lenalidomide, and Dexamethaso… Recruiting

2024-511855-16-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) vs Investigator’s Choice in Participants… Recruiting

2024-519152-82-00 Phase III 8 countries Celgene Corp.
A clinical study of MK-5684 in people with certain solid tumors (MK-5684-015) Recruiting

2024-519563-18-00 Phase II/III 1 country Merck Sharp & Dohme LLC
Bevacizumab for the treatment of cerebral RAdiation Induced NecrosiS (BRAINS) study: A multicenter, open-label, randomized clinical trial to… Recruiting

2024-512466-34-00 Phase III 1 country Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
TAILORED-PROM: Personalized therapeutic approach for preterm premature rupture of membranes to safely prolong pregnancy, enhance maternal an… Recruiting

2024-520237-77-00 Phase III 1 country Vseobecna Fakultni Nemocnice V Praze
Phase 3 Study of I-DXd Versus Docetaxel in mCRPC Recruiting

2024-517423-40-00 Phase III 13 countries Merck Sharp & Dohme LLC
A clinical study of zilovertamab vedotin in people with large B-cell lymphoma (MK-2140-010) Recruiting

2024-515566-13-00 Phase III 11 countries Merck Sharp & Dohme LLC
A trial to learn if AZD0486 alone or with other anticancer drugs is safe and works in adults with certain blood cancers Recruiting

2024-515034-33-00 Phase I/II 5 countries AstraZeneca AB
Randomised, double-blind, multicentre, phase III clinical trial to evaluate the efficacy and safety of dexamethasone compared to placebo in … Recruiting

2024-513209-30-00 Phase III 1 country Fundacion De La Comunitat Valenciana Para La Gestion Del Instituto De Investigac…
Efficacy and safety trial of GNT0003 following imlifidase pre-treatment in participants aged 16 years and older with severe Crigler-Najjar s… Recruiting

2023-510405-18-00 Phase II 1 country Genethon
Induction therapy for lupus nephritis with no added oral corticosteroids : An open label randomised multicentre controlled trial comparing … Recruiting

2024-516242-19-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A Phase 2 Study to Evaluate Safety and Efficacy of Teclistamab-,Talquetamab- and JNJ-79635322-based Combination Regimens in Participants wit… Recruiting

2024-517382-17-00 Phase II 1 country Universitaetsklinikum Heidelberg AöR
An Open Label, Phase 2 Study to Evaluate Activity and Safety of Daratumumab in combination with Bortezomib and Dexamethasone in patients wit… Recruiting

2024-511635-94-00 Phase II 1 country Fondazione Italiana Linfomi Ets
Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing - The INSTAR study Recruiting

2024-515350-25-01 Phase IV 3 countries St. Olavs Hospital HF
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer Ended

2024-512998-27-00 Phase III 15 countries Genmab A/S

Showing 1–24 of 46 trials

← All drugs A–Z